BIO-TECHNE Corp Income Taxes Paid
BIO-TECHNE Corp (TECH) reported Income Taxes Paid of $42.35 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-05-06
- BIO-TECHNE Corp income taxes paid for the quarter ending 2026-03-31 was $5.67M, a 69.02% decline year-over-year.
- BIO-TECHNE Corp income taxes paid for the quarter ending 2025-12-31 was $5.87M, a 72.18% decline year-over-year.
- BIO-TECHNE Corp income taxes paid for the quarter ending 2025-09-30 was $30.81M, a 86.85% increase year-over-year.
- BIO-TECHNE Corp income taxes paid for the quarter ending 2025-03-31 was $18.31M, a 154.21% increase year-over-year.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 3 month as first filed | Income Taxes Paid 6 month | Income Taxes Paid 6 month as first filed | Income Taxes Paid 9 month | Income Taxes Paid 9 month as first filed |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $11.54M derived: sum of 2 quarters · filed 2026-05-06 | $42.35M 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $5.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $36.68M 10-Q · filed 2026-02-04 | ||||
| 2025-09-30 | $30.81M 10-Q · filed 2025-11-05 | |||||
| 2025-03-31 | $18.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $39.41M derived: sum of 2 quarters · filed 2026-05-06 | $55.90M 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | $21.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $37.59M 10-Q · filed 2026-02-04 | ||||
| 2024-09-30 | $16.49M 10-Q · filed 2025-11-05 | |||||
| 2024-03-31 | $7.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-08 | $12.05M derived: sum of 2 quarters · filed 2025-05-08 | $44.85M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $4.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-06 | $37.65M 10-Q · filed 2025-02-06 | ||||
| 2023-09-30 | $32.80M 10-Q · filed 2024-11-05 | |||||
| 2023-03-31 | $36.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06 | $47.69M derived: sum of 2 quarters · filed 2024-05-06 | $62.58M 10-Q · filed 2024-05-06 | |||
| 2022-12-31 | $11.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07 | $26.41M 10-Q · filed 2024-02-07 | ||||
| 2022-09-30 | $14.89M 10-Q · filed 2023-11-07 | |||||
| 2022-03-31 | $7.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08 | $10.89M derived: sum of 2 quarters · filed 2023-05-08 | $22.96M 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $15.37M 10-Q · filed 2023-02-07 | ||||
| 2021-09-30 | $12.07M 10-Q · filed 2022-11-07 | |||||
| 2021-03-31 | $6.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-09 | $11.92M derived: sum of 2 quarters · filed 2022-05-09 | $17.96M 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $4.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-07 | $11.01M 10-Q · filed 2022-02-07 | ||||
| 2020-09-30 | $6.03M 10-Q · filed 2021-11-08 | $6.03M 10-Q · filed 2020-11-09 | ||||
| 2020-03-31 | $17.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07 | $22.40M derived: sum of 2 quarters · filed 2021-05-07 | $24.85M 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | $4.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | $7.04M 10-Q · filed 2021-02-08 | ||||
| 2019-09-30 | $2.45M 10-Q · filed 2019-11-06 | $2.45M 10-Q · filed 2020-11-09 | ||||
| 2019-03-31 | $15.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $18.19M derived: sum of 2 quarters · filed 2020-05-11 | $26.64M 10-Q · filed 2020-05-11 | $16.11M 10-Q · filed 2019-05-07 | ||
| 2018-12-31 | $2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $10.81M 10-Q · filed 2020-02-06 | ||||
| 2018-09-30 | $8.45M 10-Q · filed 2019-11-06 | $3.23M 10-Q · filed 2018-11-07 | ||||
| 2018-03-31 | $3.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07 | $4.73M derived: sum of 2 quarters · filed 2019-05-07 | $6.88M 10-Q · filed 2019-05-07 | $31.10M 10-Q · filed 2018-05-09 | ||
| 2017-12-31 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | $3.63M 10-Q · filed 2019-02-07 | $27.87M 10-Q · filed 2018-02-08 | |||
| 2017-09-30 | $2.14M 10-Q · filed 2018-11-07 | |||||
| 2017-03-31 | $10.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $31.86M 10-Q · filed 2018-05-09 | ||||
| 2016-12-31 | $21.83M 10-Q · filed 2018-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |